115 related articles for article (PubMed ID: 30355482)
1. The Cdkn1a
Torgovnick A; Heger JM; Liaki V; Isensee J; Schmitt A; Knittel G; Riabinska A; Beleggia F; Laurien L; Leeser U; Jüngst C; Siedek F; Vogel W; Klümper N; Nolte H; Wittersheim M; Tharun L; Castiglione R; Krüger M; Schauss A; Perner S; Pasparakis M; Büttner R; Persigehl T; Hucho T; Herter-Sprie GS; Schumacher B; Reinhardt HC
Cell Rep; 2018 Oct; 25(4):1027-1039.e6. PubMed ID: 30355482
[TBL] [Abstract][Full Text] [Related]
2. Endoplasmic reticulum stress sensitizes cells to DNA damage-induced apoptosis through p53-dependent suppression of p21(CDKN1A).
Mlynarczyk C; Fåhraeus R
Nat Commun; 2014 Oct; 5():5067. PubMed ID: 25295585
[TBL] [Abstract][Full Text] [Related]
3. p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa.
Valente LJ; Gray DH; Michalak EM; Pinon-Hofbauer J; Egle A; Scott CL; Janic A; Strasser A
Cell Rep; 2013 May; 3(5):1339-45. PubMed ID: 23665218
[TBL] [Abstract][Full Text] [Related]
4. The role of p21(waf1/cip1) and p27(Kip1) in HDACi-mediated tumor cell death and cell cycle arrest in the Eμ-myc model of B-cell lymphoma.
Newbold A; Salmon JM; Martin BP; Stanley K; Johnstone RW
Oncogene; 2014 Nov; 33(47):5415-23. PubMed ID: 24292681
[TBL] [Abstract][Full Text] [Related]
5. KAISO, a critical regulator of p53-mediated transcription of CDKN1A and apoptotic genes.
Koh DI; Han D; Ryu H; Choi WI; Jeon BN; Kim MK; Kim Y; Kim JY; Parry L; Clarke AR; Reynolds AB; Hur MW
Proc Natl Acad Sci U S A; 2014 Oct; 111(42):15078-83. PubMed ID: 25288747
[TBL] [Abstract][Full Text] [Related]
6. Genetic dissection of the role of p21Cip1/Waf1 in p53-mediated tumour suppression.
Efeyan A; Collado M; Velasco-Miguel S; Serrano M
Oncogene; 2007 Mar; 26(11):1645-9. PubMed ID: 16964282
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Response to Non-genotoxic Activation of p53 by Nutlin3a Is Driven by PUMA-Mediated Apoptosis in Lymphoma Cells.
Valente LJ; Aubrey BJ; Herold MJ; Kelly GL; Happo L; Scott CL; Newbold A; Johnstone RW; Huang DC; Vassilev LT; Strasser A
Cell Rep; 2016 Mar; 14(8):1858-66. PubMed ID: 26904937
[TBL] [Abstract][Full Text] [Related]
8. p53-intact cancers escape tumor suppression through loss of long noncoding RNA Dino.
Marney CB; Anderson ES; Adnan M; Peng KL; Hu Y; Weinhold N; Schmitt AM
Cell Rep; 2021 Jun; 35(13):109329. PubMed ID: 34192538
[TBL] [Abstract][Full Text] [Related]
9. The fate of p21CDKN1A in cells surviving UV-irradiation.
Itoh T; Linn S
DNA Repair (Amst); 2005 Dec; 4(12):1457-62. PubMed ID: 16182613
[TBL] [Abstract][Full Text] [Related]
10. Role of p53 in the progression from ochratoxin A-induced DNA damage to gene mutations in the kidneys of mice.
Kuroda K; Hibi D; Ishii Y; Yokoo Y; Takasu S; Kijima A; Matsushita K; Masumura K; Kodama Y; Yanai T; Sakai H; Nohmi T; Ogawa K; Umemura T
Toxicol Sci; 2015 Mar; 144(1):65-76. PubMed ID: 25636497
[TBL] [Abstract][Full Text] [Related]
11. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53.
Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A
Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149
[TBL] [Abstract][Full Text] [Related]
12. Significance of Wild-Type p53 Signaling in Suppressing Apoptosis in Response to Chemical Genotoxic Agents: Impact on Chemotherapy Outcome.
Mirzayans R; Andrais B; Kumar P; Murray D
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28452953
[TBL] [Abstract][Full Text] [Related]
13. Lack of p21 expression links cell cycle control and appendage regeneration in mice.
Bedelbaeva K; Snyder A; Gourevitch D; Clark L; Zhang XM; Leferovich J; Cheverud JM; Lieberman P; Heber-Katz E
Proc Natl Acad Sci U S A; 2010 Mar; 107(13):5845-50. PubMed ID: 20231440
[TBL] [Abstract][Full Text] [Related]
14. The codon 72 polymorphism of p53 influences cell fate following nutrient deprivation.
Kung CP; Liu Q; Murphy ME
Cancer Biol Ther; 2017 Jul; 18(7):484-491. PubMed ID: 28475405
[TBL] [Abstract][Full Text] [Related]
15. Type C TP53-CDKN1A pathway dysfunction occurs independently of CDKN1A gene polymorphisms in chronic lymphocytic leukaemia and is associated with TP53 abnormalities.
Tracy I; Tapper W; Parker A; Gardiner A; Sadullah S; Pratt G; Copplestone A; Oscier D; Best OG
Br J Haematol; 2017 Sep; 178(5):824-826. PubMed ID: 27292869
[No Abstract] [Full Text] [Related]
16. Transient mitochondrial DNA double strand breaks in mice cause accelerated aging phenotypes in a ROS-dependent but p53/p21-independent manner.
Pinto M; Pickrell AM; Wang X; Bacman SR; Yu A; Hida A; Dillon LM; Morton PD; Malek TR; Williams SL; Moraes CT
Cell Death Differ; 2017 Feb; 24(2):288-299. PubMed ID: 27911443
[TBL] [Abstract][Full Text] [Related]
17. NBPF1, a tumor suppressor candidate in neuroblastoma, exerts growth inhibitory effects by inducing a G1 cell cycle arrest.
Andries V; Vandepoele K; Staes K; Berx G; Bogaert P; Van Isterdael G; Ginneberge D; Parthoens E; Vandenbussche J; Gevaert K; van Roy F
BMC Cancer; 2015 May; 15():391. PubMed ID: 25958384
[TBL] [Abstract][Full Text] [Related]
18. Resistance for Genotoxic Damage in Mesenchymal Stromal Cells Is Increased by Hypoxia but Not Generally Dependent on p53-Regulated Cell Cycle Arrest.
Lützkendorf J; Wieduwild E; Nerger K; Lambrecht N; Schmoll HJ; Müller-Tidow C; Müller LP
PLoS One; 2017; 12(1):e0169921. PubMed ID: 28081228
[TBL] [Abstract][Full Text] [Related]
19. Epithelial derived-matrix metalloproteinase (MMP9) exhibits a novel defensive role of tumor suppressor in colitis associated cancer by activating MMP9-Notch1-ARF-p53 axis.
Walter L; Pujada A; Bhatnagar N; Bialkowska AB; Yang VW; Laroui H; Garg P
Oncotarget; 2017 Jan; 8(1):364-378. PubMed ID: 27861153
[TBL] [Abstract][Full Text] [Related]
20. Selenoprotein W depletion induces a p53- and p21-dependent delay in cell cycle progression in RWPE-1 prostate epithelial cells.
Hawkes WC; Printsev I; Alkan Z
J Cell Biochem; 2012 Jan; 113(1):61-9. PubMed ID: 21866568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
